Total investments received (USD): 21.46m
Round value (USD): 12.9m
Round investors:
BGF
IQ Capital Partners
Meltwind
Merck Ventures
Octopus Ventures
Eli Lilly and Company
Company: NanoSyrinx
Industry:
Biotech
Health services








Belgium
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal